Hanall Biopharma Co., Ltd. (KRX: 009420)
South Korea
· Delayed Price · Currency is KRW 40,900
+400 (0.99%)
Nov 15, 2024, 3:30 PM KST
Hanall Biopharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 2,008,065 | 2,245,705 | 902,290 | 1,077,892 | 1,919,220 | 1,857,720 | Upgrade
|
| Market Cap Growth | 49.16% | 148.89% | -16.29% | -43.84% | 3.31% | 0.28% | Upgrade
|
| Enterprise Value | 1,973,231 | 2,185,410 | 836,710 | 991,822 | 1,831,333 | 1,751,334 | Upgrade
|
| Last Close Price | 39600.00 | 44300.00 | 17800.00 | 21050.00 | 37500.00 | 36300.00 | Upgrade
|
| PE Ratio | - | 640.04 | 3596.90 | 121.16 | 97.10 | 96.89 | Upgrade
|
| Forward PE | 92.89 | 261.09 | 112.30 | 65.12 | 88.99 | 108.36 | Upgrade
|
| PS Ratio | 15.37 | 16.65 | 8.20 | 10.61 | 21.66 | 17.13 | Upgrade
|
| PB Ratio | 11.79 | 12.06 | 5.36 | 6.59 | 10.59 | 13.23 | Upgrade
|
| P/TBV Ratio | 12.14 | 12.18 | 5.43 | 6.68 | 10.74 | 13.52 | Upgrade
|
| P/FCF Ratio | 93.06 | 82.47 | 40.22 | - | - | 101.14 | Upgrade
|
| P/OCF Ratio | 66.66 | 75.76 | 35.71 | 1283.40 | 2065.25 | 90.66 | Upgrade
|
| PEG Ratio | 19.09 | 19.09 | 19.09 | 19.09 | 30.68 | 7.78 | Upgrade
|
| EV/Sales Ratio | 15.14 | 16.20 | 7.61 | 9.76 | 20.67 | 16.15 | Upgrade
|
| EV/EBITDA Ratio | - | 437.92 | 183.55 | 77.34 | 207.41 | 88.43 | Upgrade
|
| EV/EBIT Ratio | - | 1253.51 | 555.66 | 98.21 | 308.56 | 102.48 | Upgrade
|
| EV/FCF Ratio | 91.45 | 80.26 | 37.30 | - | - | 95.35 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.26 | 0.29 | 0.10 | 0.06 | 0.03 | Upgrade
|
| Debt / FCF Ratio | 0.05 | 0.05 | 0.06 | - | - | 0.03 | Upgrade
|
| Asset Turnover | 0.59 | 0.60 | 0.53 | 0.49 | 0.43 | 0.61 | Upgrade
|
| Inventory Turnover | 2.28 | 2.08 | 2.11 | 2.05 | 2.26 | 3.13 | Upgrade
|
| Quick Ratio | 2.00 | 2.10 | 2.97 | 4.35 | 4.61 | 4.31 | Upgrade
|
| Current Ratio | 3.14 | 3.02 | 3.92 | 5.37 | 5.61 | 4.90 | Upgrade
|
| Return on Equity (ROE) | -3.56% | 1.98% | 0.15% | 5.16% | 12.29% | 14.90% | Upgrade
|
| Return on Assets (ROA) | -2.11% | 0.48% | 0.46% | 3.02% | 1.80% | 6.04% | Upgrade
|
| Return on Capital (ROIC) | -2.65% | 0.61% | 0.56% | 3.64% | 2.30% | 8.28% | Upgrade
|
| Earnings Yield | -0.31% | 0.16% | 0.03% | 0.83% | 1.03% | 1.03% | Upgrade
|
| FCF Yield | 1.07% | 1.21% | 2.49% | -0.35% | -0.09% | 0.99% | Upgrade
|
| Buyback Yield / Dilution | 0.33% | 0.24% | 0.76% | -0.05% | -0.00% | - | Upgrade
|
| Total Shareholder Return | 0.33% | 0.24% | 0.76% | -0.05% | -0.00% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.